Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Milhan, Telatar"'
Autor:
Fei Fei, Caitlin Caporale, Lisa Chang, Barbara K. Fortini, Haris Ali, Diana Bell, Anthony Stein, Guido Marcucci, Milhan Telatar, Michelle Afkhami
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5183 (2024)
BRAF mutations are rare in myeloid neoplasms and are reported to be associated with poor treatment outcomes. The purpose of our study is to characterize BRAF mutations in myeloid neoplasms using a next-generation sequencing (NGS) panel based on the e
Externí odkaz:
https://doaj.org/article/d07f281057a848bebdb3fa543565c347
Autor:
Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Pourhassan, Vaibhav Agrawal, Paul Koller, Shukaib Arslan, Vanina Tomasian, Monzr M. Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Brian Ball, Salman Otoukesh, Idoroenyi Amanam, Pamela S. Becker, Forrest M. Stewart, Peter Curtin, Eileen Smith, Milhan Telatar, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat
Publikováno v:
American Journal of Hematology. 98:848-856
Autor:
Ibrahim Aldoss, Dongyun Yang, Michelle Afkhami, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Vaibhav Agrawal, Hoda Pourhassan, Paul B. Koller, Vanina Tomasian, Milhan Telatar, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Shukaib Arslan, Brian J Ball, Salman Otoukesh, Idoroenyi Amanam, Andrew S. Artz, Pamela S. Becker, Forrest M. Stewart, Peter T. Curtin, Raju Pillai, Eileen P. Smith, Guido Marcucci, Anthony S. Stein, Stephen J Forman, Ryotaro Nakamura, Vinod A. Pullarkat
Publikováno v:
Blood. 140:6020-6022
Autor:
Michelle Afkhami, Daniel Schmolze, Susan E Yost, Paul H Frankel, Andrew Dagis, Idoroenyi U Amanam, Milhan Telatar, Kim Nguyen, Kim Wai Yu, Thehang Luu, Raju Pillai, Patricia A Aoun, Joanne Mortimer, Yuan Yuan
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224726 (2019)
The goal of this study is to characterize the genomic and immune profiles of metaplastic breast cancer (MpBC) and identify the association with survival through an analysis of archived tumor tissue. A next-generation sequencing-based mutational assay
Externí odkaz:
https://doaj.org/article/55bd025cde8f4ee8857bf5de40ab60c7
Autor:
Ibrahim Aldoss, Anh Pham, Sierra Min Li, Ketevan Gendzekhadze, Michelle Afkhami, Milhan Telatar, Hao Hong, Abbas Padeganeh, Victoria Bedell, Thai Cao, Samer K Khaled, Monzr M Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Joycelynne Palmer, Patricia Aoun, Ricardo Spielberger, Anthony S Stein, David Snyder, Margaret R O’Donnell, Joyce Murata-Collins, David Senitzer, Dennis Weisenburger, Stephen J Forman, Vinod Pullarkat, Guido Marcucci, Raju Pillai, Ryotaro Nakamura
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Therapy-related myelodysplastic syndrome is a long-term complication of cancer treatment in patients receiving cytotoxic therapy, characterized by high-risk genetics and poor outcomes. Allogeneic hematopoietic cell transplantation is the only potenti
Externí odkaz:
https://doaj.org/article/2cbc02b28f35462299c83c28a89d386c
Autor:
Ibrahim Aldoss, Dongyun Yang, Vanina Tomasian, Sally Mokhtari, Ryan Jackson, Zhaohui Gu, Milhan Telatar, Hooi Yew, Monzr M. Al Malki, Amandeep Salhotra, Samer Khaled, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Matthew Mei, Shukaib Arslan, Paul Koller, Andrew Artz, Patricia Aoun, Dongqing Gu, David Snyder, Forrest M. Stewart, Peter Curtin, Anthony S. Stein, Raju Pillai, Guido Marcucci, Stephen J. Forman, Vinod Pullarkat, Ryotaro Nakamura, Michelle Afkhami
Publikováno v:
Blood advances. 6(17)
Allogenic hematopoietic cell transplantation (alloHCT) is a well-established curative modality for acute lymphoblastic leukemia (ALL), yet large amounts of data describing alloHCT outcomes in Philadelphia (Ph)-like ALL are lacking. We retrospectively
Autor:
David S. Snyder, Sally Mokhtari, Milhan Telatar, Guido Marcucci, Margaret R. O'Donnell, Vinod Pullarkat, Dongqing Gu, Samer K. Khaled, Stephen J. Forman, Monzr M. Al Malki, Raju Pillai, Ahmed Aribi, Elizabeth Budde, Anthony S. Stein, Ibrahim Aldoss, Dennis D. Weisenburger, Ryotaro Nakamura, Patricia Aoun, Karamjeet S. Sandhu, Matthew Mei, Amandeep Salhotra, Haris Ali, Dongyun Yang, Diana Weigel, Michelle Afkhami, Joyce Murata-Collins
Publikováno v:
Clin Lymphoma Myeloma Leuk
Background Mutations in isocitrate dehydrogenase (IDH)1/2 genes result in nicotinamide adenine dinucleotide phosphate-dependent reduction of α-ketoglutarate and formation of 2-hydroxyglutarate, which blocks normal cellular differentiation and promot
Autor:
Justine A. Barletta, Jochen H. Lorch, Fei Dong, Nancy L. Cho, Erik K. Alexander, Matthew A. Nehs, Michelle Afkhami, Ellen Marqusee, Gerard M. Doherty, Kristine S. Wong, Milhan Telatar
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 31(6)
Background: Similar to poorly differentiated thyroid carcinoma (PDTC), papillary thyroid carcinoma with high-grade features (PTC HGF) demonstrates increased mitotic activity and/or necrosis; howeve...
Autor:
Dongqing Gu, Vinod Pullarkat, David S. Snyder, Hooi Yew, Sally Mokhtari, Milhan Telatar, Samer Khaled, Shukaib Arslan, Ibrahim Aldoss, Matthew Mei, Paul Koller, Stephen J. Forman, Haris Ali, Anthony S. Stein, Patricia Aoun, Vanina Tomazian, Monzr M. Al Malki, F. Mark Stewart, Guido Marcucci, Karamjeet S. Sandhu, Zhaohui Gu, Andrew S. Artz, Peter T. Curtin, Raju Pillai, Michelle Afkhami, Ahmed Aribi, Ryan Jackson, Ryotaro Nakamura, Amandeep Salhotra, Dongyun Yang
Publikováno v:
Blood. 138:3955-3955
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) represents 20% of newly diagnosed adults with B cell ALL (B-ALL), with increased frequency in adults with Hispanic ethnicity. Ph-like ALL harbors a diverse range of genetic alter
Autor:
Victoria Bedell, Ricardo Spielberger, Ketevan Gendzekhadze, Vinod Pullarkat, Thai Cao, Raju Pillai, Anh Pham, David S. Snyder, Ahmed Aribi, Stephen J. Forman, Sierra Min Li, Milhan Telatar, Monzr M. Al Malki, Hao Hong, Dennis D. Weisenburger, Samer K. Khaled, David Senitzer, Abbas Padeganeh, Joyce Murata-Collins, Patricia Aoun, Ibrahim Aldoss, Haris Ali, Ryotaro Nakamura, Joycelynne Palmer, Guido Marcucci, Amandeep Salhotra, Michelle Afkhami, Margaret R. O'Donnell, Anthony S. Stein
Publikováno v:
Haematologica
Therapy-related myelodysplastic syndrome is a long-term complication of cancer treatment in patients receiving cytotoxic therapy, characterized by high-risk genetics and poor outcomes. Allogeneic hematopoietic cell transplantation is the only potenti